Hikma Injectables Portugal site visit

London, 30 November 2022 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, is today hosting sell side analysts at its Injectables manufacturing facility in Sintra, Portugal.

Press Release Corporate 30 November 2022

text 1

The visit will primarily provide the opportunity for attendees to tour this state-of-the-art facility which serves as a global hub for the Injectables business, the largest of Hikma’s three divisions. Senior members of the Injectables team will also present on the unique fundamentals of the business, which has a solid track record of revenue growth and strong margins. No new material information will be provided.

The presentation is available on Hikma’s website - click here.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.